Stock Alert: Vaxart Up 14% After Dosing First Patient In Oral COVID-19 Vaccine Trial
Shares of Vaxart Inc. (VXRT), a San Francisco-based clinical-stage biotechnology company, are climbing more than 14 percent or $1.02 in Tuesday’s morning trade at $8.07.
Tuesday, Vaxart said that the first subject has been dosed in its Phase 1 study of VXA-CoV2-1, an oral tablet COVID-19 vaccine candidate. The Phase 1, open-label, dose-ranging trial, NCT04563702, is designed to examine the safety and immunogenicity of two doses of VXA-CoV2-1 in up to 48 healthy adult volunteers aged 18 to 54 years old.
Vaxart said that enrollment is expected to be completed by early November 2020, with participants receiving the low or high dose of the VXA-CoV2-1 oral tablet at days 1 and 29. Safety, reactogenicity and immunogenicity assessments will be performed at set times during the active phase. The company is looking forward to receiving the first clinical data in the next few weeks.
Vaxart has traded in a range of $0.27 to $17.49 in the past 52 weeks.
European Economics Preview: Germany’s Industrial Production Data Due
Industrial production from Germany and house prices from the UK are due on Wednesday, headlining a light day for the European economic news.
At 2.00 am ET, Destatis is scheduled to issue Germany’s industrial output for August. Economists forecast output to grow 1.5 percent on month, following a 1.2 percent rise in July.
In the meantime, industrial production figures are due from Norway and Denmark.
At 2.45 am ET, foreign trade and current account figures are due from France.
At 3.00 am ET, Spain’s INE releases industrial output for August. Economists expect production to decline 5.7 percent on year, after easing 6.4 percent in July.
Also, industrial and construction output and foreign trade figures are due from the Czech Republic. Industrial production is seen falling 2.8 percent annually, after easing 5 percent in July.
At 3.30 am ET, UK Halifax house price data is due. Economists forecast house prices to rise 1.5 percent on month in September, following a 1.6 percent rise in August.
At 4.00 am ET, Italy’s Istat is scheduled to issue retail sales for August. Sales had decreased 2.2 percent on month in July.
At 4.55 am ET, the Central Bank of Iceland will publish the statement of the Monetary Policy Committee, including the Committee’s interest rate decision.
At 7.00 am ET, Poland’s central bank is set to announce its interest rate decision. The bank is expected to hold its key rate at 0.10 percent.
Stock Alert: The Peck Company Climbs 7% On Securing $7 Mln Worth Contracts
Shares of solar engineering, procurement and construction services provider The Peck Company Holdings, Inc. (PECK) are climbing more than 7% Tuesday morning on the news of signing $7.641 million worth contracts.
The contract are for six projects totaling 10.5 megawatts located in Vermont.
According to the Solar Energy Industry Association, Vermont is expected to install an additional 251 megawatts of solar PV projects through 2025.
currently, the stock is at $9.05. It has been trading in the range of $1.49- $14.42 in the last one year.
Wipro Q2 Profit Down 3.4%; Approves Buyback Of Up To $1.3 Bln Of Shares
India-based software services company Wipro Ltd. (WIT) reported that its profit attributable to equity holders of the company for the second-quarter ended September 30, 2020 was 24.7 billion Indian rupees or $335.3 million, a decrease of 3.4% from last year. Earnings per share for the quarter was 4.33 rupees or $0.06, an increase of 0.7% from the prior year.
Gross revenue was 151.1 billion rupees or $2.1 billion, a decrease of 0.1% from the prior year.
Looking ahead for the third-quarter ending December 31, 2020, the company expects revenue from its IT Services business to be in the range of $2.022 billion to $2.062 billion, representing a sequential growth of 1.5% to 3.5%.
Wipro’s board has approved a buyback proposal for purchase of up to 237.5 million equity shares from the shareholders of the company for the price of 400 rupees per equity share or $5.4 per share for an aggregate amount not exceeding 95 billion rupees or $1.3 billion.
Mum and three kids killed in A40 crash pictured as dad and baby fight for lives
A mother and her three children who died in a crash on the A40 near Oxford have been named.
Zoe Powell, 29, was killed alongside Phoebe, eight, Amelia, four, and Simeon, six, when a lorry crashed into the family’s silver Subaru people carrier at around 9.50pm last night.
Her husband Josh, 30, and their 18-month-old baby girl were both critically injured and are now now fighting for their lives in Oxford’s John Radcliffe Hospital.
More to follow.
Stock Alert: Altimmune Jumps 19%
Shares of Altimmune Inc. (ALT) are gaining more than 19 percent or $2.43 in Tuesday’s morning trade at $15.03.
Monday, Altimmune pre-published a comprehensive preclinical evaluation of its single-dose, intranasal COVID-19 vaccine candidate, AdCOVID. The studies were conducted as part of Altimmune’s ongoing collaboration with the University of Alabama at Birmingham or UAB.
Altimmune said that a single intranasal dose of AdCOVID given to two strains of mice uniquely stimulated three key immune components: serum neutralizing antibody, T cell responses, and mucosal immunity in the respiratory tract. The company noted that nasal mucosal immunity may be the critical factor in driving sterilizing immunity and preventing further spread of the virus by vaccinated individuals.
Altimmune expects to file an IND with the FDA and commence a phase I safety and immunogenicity trial of AdCOVID in the fourth quarter of 2020.
Altimmune has traded in a range of $1.51 to $35.10 in the past 52 weeks.